Invokana diabetes drug faces Canadian class-action lawsuit

The diabetes drug Invokana, recently adopted by Nova Scotia's pharmacare program, is now the subject of a national class-action lawsuit.

from CBC | Health News http://ift.tt/1Nzh8pu